This brand name is authorized in Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom, United States
The drug FINTEPLA contains one active pharmaceutical ingredient (API):
1
Fenfluramine
UNII 3KC089243P - FENFLURAMINE HYDROCHLORIDE
|
Fenfluramine is a serotonin releasing agent, and thereby stimulates multiple 5-HT receptor sub-types through the release of serotonin. Fenfluramine may reduce seizures by acting as an agonist at specific serotonin receptors in the brain, including the 5-HT1D, 5-HT2A, and 5-HT2C receptors, and also by acting on the sigma-1 receptor. The precise mode of action of fenfluramine in Dravet syndrome and Lennox-Gastaut syndrome is not known. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
FINTEPLA Oral solution | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N03AX26 | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1835906, 1835917, 1835928, 1835939 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1201491001 |
Country: FR | Base de données publique des médicaments | Identifier(s): 62154820 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 397999, 398001, 398002 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9014 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049286014, 049286026, 049286038, 049286040 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1139016S1020 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091688, 1091689, 1091690, 1091691 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100446075 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68995001, W68995002, W68995003, W68995004 |
Country: US | FDA, National Drug Code | Identifier(s): 43376-322 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.